Home › Obesity › Texas › Amarillo

Pag-aaral pangklinika para sa Obesity sa Amarillo, TX

Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Amarillo. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Nagre-recruitPhase 2

Amarillo Medical Specialists /ID# 282380, Amarillo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3

Amarillo Medical Specialists, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Nagre-recruitPhase 3

Amarillo Med Spec LLP, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3

Amarillo Medical Specialists, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07339423

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3

PharmaTex Research, LLC, Amarillo

Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Nagre-recruitPhase 3

PharmaTex Research, LLC, Amarillo

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Nagre-recruitPhase 3

Kailera Clinical Site, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Nagre-recruitPhase 3

Kailera Clinical Site, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284875

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Nagre-recruitPhase 3

PharmaTex Research, LLC, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07567001

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Nagre-recruitPhase 1

Amarillo Medical Specialists, Amarillo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2026 · NCT07607587

Pag-aaral para sa Obesity sa ibang lungsod

Iba pang pag-aaral sa Amarillo

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.